|Basic InformationMore InformationLatest News|Scientists Can't Replicate Surprising Finding on Alzheimer's TreatmentSleep Apnea in Seniors Tied to Alzheimer's in StudyExperimental Drug Seems to Aid Memory in Mice With Alzheimer'sHigh Blood Sugar May Add to Alzheimer's Risk: StudyLiving Long May Protect Against Early Alzheimer's, Study FindsGeneral Anesthesia Not Linked to Raised Risk for DementiaMediterranean Diet Might Help Stave Off DementiaSex Lives Often an Overlooked Casualty of Traumatic Brain InjuryGene Studies Could Point to New Alzheimer's TreatmentsGenetics Linked to Abnormal Alzheimer's MarkersAlzheimer's Patients May Face Looming Shortage of NeurologistsBrain Changes Seen in Relatives of People With Alzheimer'sExercise Benefits Physical Functioning in Alzheimer'sExercise May Help People With Alzheimer's Avoid Nursing HomesNewly Created Rats Designed to Speed Alzheimer's ResearchGene May Double Risk of Alzheimer's in BlacksAnnual Cost of Dementia About $200 Billion in U.S.Heart Risks May Also Point to Dementia RiskResearchers Test Implanted Brain Stimulator for Alzheimer'sEarly Thinking Problems May Signal Future Dementia in Parkinson's PatientsA Third of U.S. Seniors Die With Dementia, Study FindsHigh Blood Pressure May Add to Alzheimer's Risk, Study FindsFDA Wants to Relax Approval Process for Alzheimer's DrugsSingle Concussion May Lead to Lasting Brain DamageExperimental Alzheimer's Drug Shows Promise, Study FindsImproving Eating Habits Cuts Depression in DementiaHealth Tip: Spot the Early Stages of Alzheimer'sAtrial Fibrillation Associated With Cognitive ImpairmentMore Regular Meals May Improve Dementia CarePossible Therapeutic Window ID'd to Treat Memory ProblemsFor Alzheimer's Caregivers, Patience and Compassion Are KeyWhite Matter Hyperintensities Tied to Alzheimer's DiseaseAntioxidant Capacity of Diet Not Tied to Dementia, Stroke RiskDamage to Tiny Blood Vessels in Brain May Raise Alzheimer's RiskWomen With Alzheimer's-Linked Gene Show Faster Cell AgingNumber of Americans With Alzheimer's May Triple by 2050Review Finds No Evidence Alzheimer's, Parkinson's Are InfectiousPET Scans Helpful, But Not Definitive for Alzheimer's DiagnosisU.S. Launches Extensive Alzheimer's StudiesData Suggest Depression Doesn't Precede Impaired CognitionDementia, Late-Life Depression May Be LinkedFuture Astronauts May Be Exposed to Alzheimer's Risk FactorAlzheimer's Trial Participation Linked to Study PartnerMRI, PET, and CSF Biomarkers Up Prediction of Alzheimer'sLoneliness May Boost Odds of DementiaHealth Tip: If Dementia Causes Sleep ProblemsRSNA: Gender Affects Patterns of Brain Atrophy in Alzheimer'sScientists ID Gene Mutation That May Triple Alzheimer's RiskCommunication Dilemmas ID'd Within Alzheimer's CareFamily's Questions About Alzheimer's Patients Can Put Nurses in a BindQuestions and AnswersLinksBook Reviews
Brain Tracer Indicates Risk of Future Cognitive Decline
Updated: Jul 13th 2012
FRIDAY, July 13 (HealthDay News) -- A radioactive tracer that can image amyloid-beta deposits in the brain can indicate whether older adults are at risk of cognitive decline and developing Alzheimer's disease, according to a study published online July 11 in Neurology.
P. Murali Doraiswamy, M.D., from the Duke University Medical Center in Durham, N.C., and colleagues performed florbetapir F 18 positron emission tomography (PET), which images amyloid-beta, on 151 older subjects. Of these, 69 were cognitively normal, 51 had been recently diagnosed with mild cognitive impairment, and 31 had been diagnosed with Alzheimer's disease dementia.
Over the course of 36 months the researchers found that normal and mildly impaired patients who had been positive for amyloid-beta at baseline showed clinical worsening on two cognitive tests. Mildly impaired patients who were positive for amyloid-beta also showed worsening on additional cognitive tests, and those with higher cerebral to cerebellar standardized uptake value ratios at baseline also had declining scores on several cognitive tests. Mildly impaired patients were more likely to develop Alzheimer's disease dementia if they were positive for amyloid-beta at baseline.
"Our findings and other reports suggest that amyloid PET tracers may have promise for indicating risk of subsequent cognitive decline in patients with mild cognitive impairment and cognitively normal older adults," Doraiswamy and colleagues conclude.
The study was funded by Eli Lilly/Avid Radiopharmaceuticals; several authors are employed by the company. Many authors disclosed financial ties to the pharmaceutical industry.
Full Text (subscription or payment may be required)
This article: Copyright © 2012 HealthDay. All rights reserved.